Parkinson's Disease Trial, Recruiting NCT05198076 Sponsor: Cairo University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT05198076
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with idiopathic (naturally occurring) Parkinson's disease according to a standard set of UK diagnostic guidelines called the UK Parkinson's Disease Brain Bank Criteria.
  • People whose Parkinson's disease is rated as mild to moderate in severity, based on standard assessment scales used by doctors.
  • People who have been living with Parkinson's disease for between two and five years.
  • People who are in stable physical and mental health and have a healthy enough heart function.
  • People who have never previously received a treatment called rTMS (repetitive transcranial magnetic stimulation), which uses magnetic pulses applied to the head.
  • People who have signed a consent form agreeing to take part in the trial.

Who may not be able to join:

  • People who have an implanted medical device (such as a pacemaker), a serious medical illness, or a history of seizures (epilepsy or fits).
  • People who experience severe freezing episodes (where movement suddenly stops) or severe tremors (uncontrollable shaking).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Engy BadrEldin S Moustafa, PhD, Cairo University

Phone: 00201099445112

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
23 July 2025
Est. completion
18 December 2025

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Overall stability index (OSI); Antero-posterior Stability index (APSI); Medio-lateral stability index (MLSI); Directional control percent; Time to complete test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov